Open access
Open access
Powered by Google Translator Translator

All Posts

Registry Analysis | Incidence and impact of pacemaker implantation after TAVR with self-expanding valves

8 Aug, 2023 | 13:29h | UTC

Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves – JACC: Cardiovascular Interventions (link to abstract – $ for full-text)

Commentaries:

Permanent pacemakers after TAVR: Tracking the impact of modern self-expanding valves – Cardiovascular Business

Pacemaker Implantation Still Risky, Not Rare With Self-Expanding TAVI Devices – TCTMD

 


Review | Interventional cardio-oncology: unique challenges and considerations in a high-risk population

8 Aug, 2023 | 13:27h | UTC

Interventional Cardio-Oncology: Unique Challenges and Considerations in a High-Risk Population – Current Treatment Options in Oncology

 


RCT | Exploring the impact of total pancreatectomy with islet autotransplantation to reduce postoperative complications

8 Aug, 2023 | 13:25h | UTC

Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-risk Pancreatojejunostomy After Pancreaticoduodenectomy: A Prospective Randomized Trial – Annals of Surgery

 


Cohort Study | Habitual calcium supplementation linked to higher CVD incidence and mortality in diabetics

8 Aug, 2023 | 13:24h | UTC

Associations of Habitual Calcium Supplementation With Risk of Cardiovascular Disease and Mortality in Individuals With and Without Diabetes – Diabetes Care (link to abstract – $ for full-text)

Related: The Evidence and Controversy Between Dietary Calcium Intake and Calcium Supplementation and the Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Cohort Studies and Randomized Controlled Trials – Journal of the American College of Nutrition

 

Commentary on Twitter

 


Determination of “borderline resectable” pancreatic cancer – A global assessment of 30 shades of grey

8 Aug, 2023 | 13:22h | UTC

Determination of “borderline resectable” pancreatic cancer – A global assessment of 30 shades of grey – HPB

 

Commentary on Twitter

 


Consensus Paper | Minimally invasive pancreatic surgery

8 Aug, 2023 | 13:20h | UTC

The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS) – Annals of Surgery

 


Review | Management of hypocalcemia in the critically ill

8 Aug, 2023 | 13:19h | UTC

Management of hypocalcaemia in the critically ill – Current Opinion in Critical Care

 


Review | Regional anesthesia in the emergency department outside the operating theatre

8 Aug, 2023 | 13:17h | UTC

Regional anesthesia in the emergency department outside the operating theatre – Current Opinion in Anaesthesiology

 


Review | Local anesthetic adjuncts for peripheral nerve blockade

8 Aug, 2023 | 13:16h | UTC

Local anaesthetic adjuncts for peripheral nerve blockade – Current Opinion in Anaesthesiology

 


Cohort Study | Clozapine, but not olanzapine or quetiapine, linked with higher perimyocarditis and heart failure risk

8 Aug, 2023 | 13:14h | UTC

The association between exposure to clozapine, olanzapine, and quetiapine and the outcomes perimyocarditis and heart failure: A population-based cohort study – Psychiatry Research

 


Nationwide Study | Examining survival rates and risk factors in 237 drowned patients receiving ECMO

8 Aug, 2023 | 13:13h | UTC

Results from 237 extracorporeal membrane oxygenation runs with drowned patients: a nationwide retrospective study – Critical Care

 


Systematic Review | Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer

8 Aug, 2023 | 13:11h | UTC

Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer – Cochrane Library

 


M-A | The global prevalence of human fascioliasis

8 Aug, 2023 | 13:10h | UTC

The global prevalence of human fascioliasis: a systematic review and meta-analysis – Therapeutic Advances in Infectious Disease

 


Cohort Study | Potential negative survival impact of PPI and palbociclib co-administration in breast cancer patients

8 Aug, 2023 | 13:07h | UTC

Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer – JAMA Network Open

Commentary: Proton Pump Inhibitors May Compromise Efficacy of Palbociclib in Patients With Breast Cancer – Cancer Therapy Advisor

 


Clinical Trial Update | Long-term Givosiran treatment shows sustained acute hepatic porphyria symptom improvement

8 Aug, 2023 | 13:05h | UTC

Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial – Journal of Hepatology

Original Study: Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria – New England Journal of Medicine

 


NICE Updated Guideline | Venous thromboembolic diseases

7 Aug, 2023 | 15:05h | UTC

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing  – National Institute for Health and Care Excellence

 


Review | Management of worsening heart failure with reduced ejection fraction

7 Aug, 2023 | 15:03h | UTC

Management of Worsening Heart Failure With Reduced Ejection Fraction: JACC Focus Seminar 3/3 – Journal of the American College of Cardiology

 

Commentary on Twitter

 


Cohort Study | High-sensitivity troponin’s role in assessing MI and CV death risk in stable CAD patients

7 Aug, 2023 | 15:01h | UTC

High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentaries:

High-Sensitivity Troponin Assays May Stratify Risk in Chronic CAD – TCTMD

High-Sensitivity Cardiac Troponin for Risk Assessment in Chronic CAD – Journal of the American College of Cardiology

 

Commentary on Twitter

 


Survey | The manifold costs of being a non-native English speaker in science

7 Aug, 2023 | 15:00h | UTC

The manifold costs of being a non-native English speaker in science – PLOS Biology

Commentary from the author: Non-native English speaking scientists work much harder just to keep up, global research reveals – The Conversation

News Releases:

The cost of being a non-native English speaker in science – PLOS

Science language barrier could cost countless careers – University of Queensland

 

Commentary on Twitter

 


Opinion | Regulating direct-to-consumer polygenic risk scores

7 Aug, 2023 | 14:59h | UTC

Regulating Direct-to-Consumer Polygenic Risk Scores – JAMA (free for a limited period)

 


Perspective | The paradoxical decline of geriatric medicine as a profession

7 Aug, 2023 | 14:57h | UTC

The Paradoxical Decline of Geriatric Medicine as a Profession – JAMA (free for a limited period)

 

Commentary on Twitter

 


Expert Panel | Assessment and management of older adults undergoing percutaneous coronary intervention

7 Aug, 2023 | 14:55h | UTC

Assessment and Management of Older Adults Undergoing PCI, Part 1: A JACC: Advances Expert Panel – Journal of the American College of Cardiology

A Geriatric Approach to Percutaneous Coronary Interventions in Older Adults, Part II: A JACC: Advances Expert Panel – Journal of the American College of Cardiology

 


A novel comprehensive algorithm for evaluation of pediatric ICU patients with new fever or instability

7 Aug, 2023 | 14:53h | UTC

A Novel Comprehensive Algorithm for Evaluation of PICU Patients With New Fever or Instability – Pediatric Critical Care Medicine

 


ESPEN guideline on nutritional support for polymorbid medical inpatients

7 Aug, 2023 | 14:52h | UTC

ESPEN guideline on nutritional support for polymorbid medical inpatients – Clinical Nutrition

 


Phase 2 Trials | Selective NaV1.8 inhibitor, VX-548, shows potential in acute postoperative pain management

7 Aug, 2023 | 14:51h | UTC

Selective Inhibition of NaV1.8 with VX-548 for Acute Pain – New England Journal of Medicine (link to abstract – $ for full-text)

Video Summary: Selective Inhibition of NaV1.8 for Acute Pain | NEJM

Commentaries:

High-Dose VX-548 Reduces Acute Pain Post-Surgery – HCP Live

High-Dose VX-548 Reduces Acute Pain Over 48 Hours – HealthDay

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.